Bernhard Mlecnik

10PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersCancer diagnosisImmunogenetics (incl. genetic immunology)Tumour immunologyOpen access
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 10, 2026
Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

|Aug 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore.

Joseph Willis, Robert A Anders, Toshihiko Torigoe

|Jan 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.

Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea

|Sep 23, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.

Bernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea

|Aug 11, 2022
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.

Frank A Sinicrope, Qian Shi, Aurelie Catteau

|May 28, 2022
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response.

Bernardo Leon Rapoport, Simon Nayler, Bernhard Mlecnik

Pageof 2

Frequent Collaborators

4 joint publications

Marc Van den Eynde

4 joint publications

Gabriela Bindea

3 joint publications

Fabiana Tatangelo

3 joint publications

Toshihiko Torigoe